Concordare Named Finalist in 2026 Fierce AI Innovation Awards

Concordare has been named a finalist in Fierce's AI Innovation Awards, which recognize companies using AI to deliver measurable impact across life sciences and healthcare.

Our mission is to rethink the clinical trial protocol as a single, human-verified digital core, from which any stakeholder can generate documents and system configurations. This recognition reflects the real-world impact of faster, higher-quality clinical trials.

Related posts

• 
  Industry Insights

  What is a clinical trial billing grid generator? Definition and an example row

  October 2026 · 3 min read
• 
  Company News

  Concordare Pitches at WhaleTank, ING 2026

  October 6, 2026 · 1 min read
• 
  Company News

  Sam Rapp Delivers Keynote on AI in the Trial Lifecycle at ACRP NY Metro Symposium

  October 2, 2026 · 1 min read